Tandem Diabetes Care Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
2,400
- Stock Symbol
-
TNDM
- Investments
-
5
- Share Price
-
$31.91
- (As of Friday Closing)
Tandem Diabetes Care General Information
Description
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Contact Information
Website
www.tandemdiabetes.comCorporate Office
- 12400 High Bluff Drive
- Suite 100
- San Diego, CA 92130
- United States
Corporate Office
- 12400 High Bluff Drive
- Suite 100
- San Diego, CA 92130
- United States
Tandem Diabetes Care Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$31.91 | $31.37 | $13.82 - $53.69 | $2.09B | 65.5M | 1.29M | -$2.10 |
Tandem Diabetes Care Financials Summary
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 2,612,051 | 1,848,955 | 2,703,519 | 9,283,924 |
Revenue | 796,002 | 747,718 | 801,217 | 702,799 |
EBITDA | (112,622) | (219,832) | (80,266) | 33,385 |
Net Income | (136,492) | (222,611) | (94,594) | 15,566 |
Total Assets | 937,503 | 952,658 | 1,052,785 | 905,137 |
Total Debt | 477,114 | 415,667 | 419,877 | 314,668 |
Tandem Diabetes Care Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Tandem Diabetes Care Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
Tandem Diabetes Care Comparisons
Industry
Financing
Details
Tandem Diabetes Care Competitors (5)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
DexCom | Formerly VC-backed | San Diego, CA | ||||
Ellume | Formerly VC-backed | East Brisbane, Australia | ||||
POGO Automatic | Private Equity-Backed | Fremont, CA | ||||
Jana Care | Venture Capital-Backed | Watertown, MA | ||||
Medtronic Dental | Corporate Backed or Acquired | Weilrod, Germany |
Tandem Diabetes Care Patents
Tandem Diabetes Care Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240226423-A1 | User-wearable infusion pump system | Pending | 09-Jan-2023 | ||
US-20240226424-A1 | Applicator device for user-wearable infusion pump | Pending | 09-Jan-2023 | ||
US-20240050650-A1 | Ambulatory infusion pump system including pump holder | Pending | 11-Aug-2022 | ||
US-20240189504-A1 | Insulin pump with integrated continuous glucose monitor | Pending | 08-Jul-2022 | ||
US-20230381406-A1 | Filter for infusion pump systems | Pending | 24-May-2022 | A61M5/14244 |
Tandem Diabetes Care Signals
Tandem Diabetes Care Investments & Acquisitions (5)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Sigi (Therapeutic Devices) | 23-Jan-2023 | Therapeutic Devices | |||
Capillary Biomedical | 21-Jul-2022 | Therapeutic Devices | |||
CeQur Simplicity | 13-Apr-2021 | Therapeutic Devices | |||
Sugarmate | 24-Jun-2020 | Other Healthcare Technology Systems | |||
Smiths Medical (Patents and Patent Applications) | 01-Feb-2013 | Corporate Asset Purchase | Buildings and Property |
Tandem Diabetes Care Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
Sugarmate | Other Healthcare Technology Systems | San Diego, CA |
Tandem Diabetes Care ESG
Risk Overview
Risk Rating
Updated May, 31, 2024
34.83 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 16,009
Rank
Percentile
Healthcare
Industry
of 634
Rank
Percentile
Medical Devices
Subindustry
of 225
Rank
Percentile
Tandem Diabetes Care FAQs
-
When was Tandem Diabetes Care founded?
Tandem Diabetes Care was founded in 2006.
-
Where is Tandem Diabetes Care headquartered?
Tandem Diabetes Care is headquartered in San Diego, CA.
-
What is the size of Tandem Diabetes Care?
Tandem Diabetes Care has 2,400 total employees.
-
What industry is Tandem Diabetes Care in?
Tandem Diabetes Care’s primary industry is Monitoring Equipment.
-
Is Tandem Diabetes Care a private or public company?
Tandem Diabetes Care is a Public company.
-
What is Tandem Diabetes Care’s stock symbol?
The ticker symbol for Tandem Diabetes Care is TNDM.
-
What is the current stock price of Tandem Diabetes Care?
As of 01-Nov-2024 the stock price of Tandem Diabetes Care is $31.91.
-
What is the current market cap of Tandem Diabetes Care?
The current market capitalization of Tandem Diabetes Care is $2.09B.
-
What is Tandem Diabetes Care’s current revenue?
The trailing twelve month revenue for Tandem Diabetes Care is $796M.
-
Who are Tandem Diabetes Care’s competitors?
DexCom, Ellume, POGO Automatic, Jana Care, and Medtronic Dental are competitors of Tandem Diabetes Care.
-
What is Tandem Diabetes Care’s annual earnings per share (EPS)?
Tandem Diabetes Care’s EPS for 12 months was -$2.10.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »